Compare IONQ Inc (IONQ) vs Novartis AG (NVS) Price & Performance

IONQ IncTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

IONQ Inc vs Novartis AG — how do they compare? IONQ Inc trades at $43.06 (market cap $17.60B), while Novartis AG trades at $152.32 (market cap $295.37B). The key difference: Novartis AG is far larger — about 16.8× IONQ Inc's market cap, and Novartis AG pays a 3.07% dividend while IONQ Inc pays none. Which is the better fit depends on your goals.

	IONQ	NVS
Market Cap	$17.60B	$295.37B
Sector	Technology	Health
52-Week High	$82.09	$168.62
52-Week Low	$26.59	$119.31
Enterprise Value	$15.53B	$336.69B
Dividend Yield	—	3.07%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IONQ Inc

No Aura AI signal available yet.

Novartis AG

Novartis AG (NVS) trades at $156.79, up 0.29% today, with a bullish technical signal from moving averages and recent Q2 2026 earnings beating estimates. Strong profitability is evident with a 74.74% gross margin and 22.5% net margin, while revenue grew to $56.67B in 2025. The stock faces resistance near $157, with support at $156.

The outlook is positive due to robust drug pipeline progress and reaffirmed 2026 guidance, though risks include generic competition for Entresto and pricing pressures. Analyst sentiment is mixed with 24% buy ratings, but institutional buying activity supports confidence in long-term growth.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IONQ

IonQ outpaces Rigetti with 287% revenue growth and strong outlook, justifying a Buy on IONQ and Sell on RGTI.Seeking Alpha · 1 day agoBullish IonQ posts 287% revenue growth in Q2, beating expectations and boosting 2026 outlookSeeking Alpha · 2 days agoBullish View details →

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

About IONQ Inc

IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.